Does the Model for End-stage Liver Disease Score Predict Transfusion Amount, Acid–Base Imbalance, Haemodynamic and Oxidative Abnormalities during Living Donor Liver Transplantation?

Author： Lee J   Chung MY  

Publisher： Field House Publishing

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.39, Iss.5, 2011-09, pp. : 1773-1782

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging drugs for complications of end-stage liver disease

By Dowman Joanna K   Holt Andrew P   Newsome Philip N   Adams David H  

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 1, 2008-03 ,pp. : 159-174

Informa Healthcare

Access to resources Recommend Favorite

Perioperative Assessment of Terlipressin Infusion during Living Donor Liver Transplantation

By Hong SH   Lee JM   Choi JH   Chung HS   Park JH   Park CS  

The Journal of International Medical Research, Vol. 40, Iss. 1, 2012-01 ,pp. : 225-236

Field House Publishing

Access to resources Recommend Favorite

Ropivacaine clearance is reduced in chronic end-stage liver disease

By  

Inpharma, Vol. 1, Iss. 1573, 2007-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

New Management Options for End-Stage Chronic Liver Disease and Acute Liver Failure: Potential for Pediatric Patients

By Debray Dominique  

Pediatric Drugs, Vol. 8, Iss. 1, 2006-01 ,pp. : 1-13

Adis International

Access to resources Recommend Favorite